Millennium Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-63,305
Closed -$1.83M 6201
2025
Q4
$1.83M Sell
63,305
-14,684
-19% -$279K ﹤0.01% 4021
2025
Q3
$605K Sell
77,989
-5,620
-7% -$42.2K ﹤0.01% 4957
2025
Q2
$619K Buy
+83,609
New +$735K ﹤0.01% 4753
2025
Q1
Sell
-31,839
Closed -$1.14M 6299
2024
Q4
$1.14M Buy
31,839
+21,448
+206% +$1.11M ﹤0.01% 4092
2024
Q3
$491K Sell
10,391
-17,280
-62% -$762K ﹤0.01% 4842
2024
Q2
$1.39M Sell
27,671
-32,632
-54% -$2.36M ﹤0.01% 3848
2024
Q1
$6.75M Sell
60,303
-75,475
-56% -$7.5M 0.01% 2558
2023
Q4
$7.88M Buy
135,778
+48,672
+56% +$1.96M 0.01% 2397
2023
Q3
$2.77M Buy
87,106
+12,229
+16% +$581K ﹤0.01% 3251
2023
Q2
$6.16M Buy
74,877
+24,435
+48% +$3.57M 0.01% 2469
2023
Q1
$5.18M Sell
50,442
-96,099
-66% -$13.5M 0.01% 2577
2022
Q4
$21.5M Sell
146,541
-4,826
-3% -$816K 0.02% 1379
2022
Q3
$25.6M Sell
151,367
-23,941
-14% -$3.89M 0.03% 1119
2022
Q2
$20.2M Sell
175,308
-20,042
-10% -$1.88M 0.03% 1296
2022
Q1
$19.5M Buy
195,350
+169,907
+668% +$19.8M 0.02% 1425
2021
Q4
$3.96M Buy
25,443
+21,294
+513% +$4.14M ﹤0.01% 3131
2021
Q3
$978K Sell
4,149
-8,897
-68% -$2.6M ﹤0.01% 4717
2021
Q2
$4.43M Buy
13,046
+1,539
+13% +$583K 0.01% 2917
2021
Q1
$4.66M Buy
+11,507
New +$5.58M 0.01% 2648
2020
Q4
Sell
-4,008
Closed -$2.23M 5468
2020
Q3
$1.87K Sell
4,008
-27,070
-87% -$13.7M ﹤0.01% 2648
2020
Q2
$18.2M Buy
31,078
+10,546
+51% +$3.6M 0.04% 796
2020
Q1
$2.99M Sell
20,532
-11,610
-36% -$2.03M 0.01% 1735
2019
Q4
$4.6M Buy
32,142
+30,441
+1,790% +$2.23M 0.01% 2000
2019
Q3
$67K Sell
1,701
-1,098
-39% -$79.8K ﹤0.01% 4014
2019
Q2
$283K Sell
2,799
-1,030
-27% -$121K ﹤0.01% 3575
2019
Q1
$503K Buy
3,829
+2,059
+116% +$259K ﹤0.01% 3262
2018
Q4
$181K Sell
1,770
-13,019
-88% -$2.06M ﹤0.01% 3419
2018
Q3
$3.7M Buy
14,789
+9,867
+200% +$3.31M 0.01% 2021
2018
Q2
$2.2M Buy
+4,922
New +$2.16M ﹤0.01% 2329
2017
Q4
Sell
-2,210
Closed -$955K 3977
2017
Q3
$955K Sell
2,210
-231
-9% -$91K ﹤0.01% 2544
2017
Q2
$853K Buy
+2,441
New +$844K ﹤0.01% 2528

Other funds holding MRSN